Avandia (TM) - From molecule to market for type 2 diabetes.
| Data(s) |
01/04/2002
|
|---|---|
| Resumo |
Type 2 diabetes is a disease fast approaching epidemic proportions throughout the world. From insulin sensitizers to PPARg agonists, the lecture will outline the successful medicinal chem. and biol. strategy underpinning the discovery and selection of Avandia, an innovative new medicine for this disease. |
| Identificador | |
| Idioma(s) |
eng |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
Haigh , D 2002 , ' Avandia (TM) - From molecule to market for type 2 diabetes. ' Abstracts Of Papers Of The American Chemical Society , vol 223 , pp. MEDI-132-MEDI-132 . |
| Tipo |
article |
